Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Choroidal Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Not applicableStudy completedNCT01846351
What this trial is testing

Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

Who this might be right for
Epiretinal MembraneAge Related Macular Degeneration
New England Retina Associates 16
Early research (Phase 1)Study completedNCT02771340
What this trial is testing

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

Who this might be right for
Uveal MelanomaChoroid Neoplasm
Iconic Therapeutics, Inc. 10
Not applicableStudy completedNCT02612766
What this trial is testing

Safety and Tolerability of Oat Containing Gluten-free Diet

Who this might be right for
Celiac Disease
Alfred Rusescu Institute for Mother and Child Care 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927
What this trial is testing

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Elisigen, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01570790
What this trial is testing

Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Combretastatin A4 PhosphateAge-related Macular DegenerationAMD+2 more
Johns Hopkins University 8
Not applicableStudy completedNCT00596388
What this trial is testing

Usage of the Home Macular Perimeter (HMP)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 20
Not applicableEnded earlyNCT02382627
What this trial is testing

Choroidal Thickness in Optic Neuropathy

Who this might be right for
Optic Nerve Disorders
University of Colorado, Denver 2
Testing effectiveness (Phase 2)Study completedNCT02397954
What this trial is testing

Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation 4
Large-scale testing (Phase 3)Study completedNCT02307682
What this trial is testing

Efficacy and Safety of RTH258 Versus Aflibercept - Study 1

Who this might be right for
Neovascular Age-Related Macular DegenerationChoroidal Neovascularization
Alcon Research 1,775
Testing effectiveness (Phase 2)Study completedNCT00570193
What this trial is testing

Photodynamic and Pharmacologic Treatment of CNV

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
Mid-Atlantic Retina Consultations, Inc. 41
Not applicableUnknownNCT04947592
What this trial is testing

SD-OCT Guided Treatment of Fungal Chorioretinitis

Who this might be right for
Fungal Retinitis
Benha University 10
Not applicableStudy completedNCT03941587
What this trial is testing

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 60
Post-approval studies (Phase 4)Study completedNCT01006538
What this trial is testing

Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

Who this might be right for
Macular Degeneration
King's College Hospital NHS Trust 363
Early research (Phase 1)Study completedNCT00765921
What this trial is testing

Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

Who this might be right for
Choroidal Melanoma
Massachusetts Eye and Ear Infirmary 40
Not applicableStudy completedNCT01650948
What this trial is testing

Genetic Load and Phenotype in Aggressive AMD

Who this might be right for
Age-related Macular Degeneration
Sequenom, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT03052127
What this trial is testing

Study in Subjects With Small Primary Choroidal Melanoma

Who this might be right for
Uveal MelanomaOcular MelanomaChoroidal Melanoma
Aura Biosciences 57
Large-scale testing (Phase 3)Study completedNCT00436553
What this trial is testing

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis 321
Not applicableStudy completedNCT00358345
What this trial is testing

PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 347
Not applicableStudy completedNCT01864486
What this trial is testing

Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy

Who this might be right for
Retinitis PigmentosaCone Rod DystrophyChoroideremia
Science Corporation 20
Next Page